Effects of epidermal growth factor receptor‐tyrosine kinase inhibitors alone on EGFR‐mutant non‐small cell lung cancer with brain metastasis
Q Zhang, X Zhang, H Yan, B Jiang, C Xu… - Thoracic …, 2016 - Wiley Online Library
Background Epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKI s) are
remarkably effective for treating EGFR‐mutant non‐small cell lung cancer (NSCLC) …
remarkably effective for treating EGFR‐mutant non‐small cell lung cancer (NSCLC) …
Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis.
Q Zhang, X Zhang, H Yan, B Jiang, C Xu, J Yang… - Thoracic …, 2016 - europepmc.org
Background Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are
remarkably effective for treating EGFR-mutant non-small cell lung cancer (NSCLC) …
remarkably effective for treating EGFR-mutant non-small cell lung cancer (NSCLC) …
[PDF][PDF] Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis
Q Zhang, X Zhang, H Yan, B Jiang, C Xu, J Yang… - cyberleninka.org
Background: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are
remarkably effective for treating EGFR-mutant non-small cell lung cancer (NSCLC) …
remarkably effective for treating EGFR-mutant non-small cell lung cancer (NSCLC) …
[HTML][HTML] Effects of epidermal growth factor receptor‐tyrosine kinase inhibitors alone on EGFR‐mutant non‐small cell lung cancer with brain metastasis
Q Zhang, X Zhang, H Yan, B Jiang, C Xu, J Yang… - Thoracic …, 2016 - ncbi.nlm.nih.gov
Background Epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKI s) are
remarkably effective for treating EGFR‐mutant non‐small cell lung cancer (NSCLC) …
remarkably effective for treating EGFR‐mutant non‐small cell lung cancer (NSCLC) …
Effects of epidermal growth factor receptor‐tyrosine kinase inhibitors alone on EGFR‐mutant non‐small cell lung cancer with brain metastasis.
Q Zhang, X Zhang, H Yan, B Jiang, C Xu, J Yang… - Thoracic Cancer, 2016 - go.gale.com
Background: Epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) are
remarkably effective for treating EGFR‐mutant non‐small cell lung cancer (NSCLC) …
remarkably effective for treating EGFR‐mutant non‐small cell lung cancer (NSCLC) …
Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis
Q Zhang, X Zhang, H Yan, B Jiang, C Xu… - Thoracic …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are
remarkably effective for treating EGFR-mutant non-small cell lung cancer (NSCLC) …
remarkably effective for treating EGFR-mutant non-small cell lung cancer (NSCLC) …
Effects of epidermal growth factor receptor‐tyrosine kinase inhibitors alone on EGFR‐mutant non‐small cell lung cancer with brain metastasis
Q Zhang, X Zhang, H Yan, B Jiang, C Xu… - Thoracic …, 2016 - search.proquest.com
Background Epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKI s) are
remarkably effective for treating EGFR‐mutant non‐small cell lung cancer (NSCLC) …
remarkably effective for treating EGFR‐mutant non‐small cell lung cancer (NSCLC) …
Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis.
Q Zhang, X Zhang, H Yan, B Jiang, C Xu, J Yang… - Thoracic …, 2016 - europepmc.org
Background Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are
remarkably effective for treating EGFR-mutant non-small cell lung cancer (NSCLC) …
remarkably effective for treating EGFR-mutant non-small cell lung cancer (NSCLC) …